Alternative Splicing Provides a Novel Molecular Mechanism for Prostatic Small-cell Neuroendocrine Carcinoma

Affiliations

¹ Department of Urology, Affiliated Wuxi No. 2 Hospital, Nanjing Medical University, Wuxi, China; Wuxi Medical School, Jiangnan University, Wuxi, China.
² Department of Pathology, Anhui Medical University, Hefei, China; Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
³ Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
⁴ Department of Pathology, Duke University School of Medicine, Durham, NC, USA. Electronic address: jiaoti.huang@duke.edu.

Editorial

Ninghan Feng et al. Eur Urol. 2017 Jan.

. 2017 Jan;71(1):79-80.

doi: 10.1016/j.eururo.2016.07.046. Epub 2016 Jul 29.

¹ Department of Urology, Affiliated Wuxi No. 2 Hospital, Nanjing Medical University, Wuxi, China; Wuxi Medical School, Jiangnan University, Wuxi, China.
² Department of Pathology, Anhui Medical University, Hefei, China; Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
³ Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
⁴ Department of Pathology, Duke University School of Medicine, Durham, NC, USA. Electronic address: jiaoti.huang@duke.edu.

No abstract available

Comment on

SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition.
Li Y, Donmez N, Sahinalp C, Xie N, Wang Y, Xue H, Mo F, Beltran H, Gleave M, Wang Y, Collins C, Dong X. Li Y, et al. Eur Urol. 2017 Jan;71(1):68-78. doi: 10.1016/j.eururo.2016.04.028. Epub 2016 May 11. Eur Urol. 2017. PMID: 27180064